Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomio Inoue

Showing results (301-310 of 303) with videos related to

Pageof 31
Sort By:
You have reached the last page of results.This site can display upto 303 results.
Nature Cell Biology|October 17, 2022
Human induced pluripotent stem cell-derived salivary gland organoids model SARS-CoV-2 infection and replicationJunichi Tanaka, Hidenobu Senpuku, Miho Ogawa, et al.
Cancer Chemotherapy and Pharmacology|March 24, 2017
One-month assessment of renal cell carcinoma treated by everolimus using FDG PET/CT predicts progression-free and overall survivalHiroki Ito, Keiichi Kondo, Takashi Kawahara, et al.
Cancer Chemotherapy and Pharmacology|February 22, 2018
FDG PET/CT after first molecular targeted therapy predicts survival of patients with renal cell carcinomaNoboru Nakaigawa, Keiichi Kondo, Tomohiro Kaneta, et al.
Pageof 31

Showing results (301-310 of 303) with videos related to

Sort By:
Pageof 31
You have reached the last page of results.This site can display upto 303 results.
Nature Cell Biology|October 17, 2022
Human induced pluripotent stem cell-derived salivary gland organoids model SARS-CoV-2 infection and replicationJunichi Tanaka, Hidenobu Senpuku, Miho Ogawa, et al.
Cancer Chemotherapy and Pharmacology|March 24, 2017
One-month assessment of renal cell carcinoma treated by everolimus using FDG PET/CT predicts progression-free and overall survivalHiroki Ito, Keiichi Kondo, Takashi Kawahara, et al.
Cancer Chemotherapy and Pharmacology|February 22, 2018
FDG PET/CT after first molecular targeted therapy predicts survival of patients with renal cell carcinomaNoboru Nakaigawa, Keiichi Kondo, Tomohiro Kaneta, et al.
Pageof 31